search
Back to results

Prophylactic Maze to Prevent Atrial Fibrillation in Adult Cardiac Surgery (PREVENT-AF)

Primary Purpose

Coronary Artery Disease

Status
Active
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
propylactic maze
Sponsored by
Spectrum Health Hospitals
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional prevention trial for Coronary Artery Disease

Eligibility Criteria

70 Years - undefined (Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Elective cardiac surgery
  • AVR
  • CABG
  • AVR/CABG

Exclusion Criteria:

  • History of AF/Aflutter
  • Less common cardiac surgeries:
  • aortic root replacement
  • aortic dissections
  • myxoma
  • pericardectomies
  • off-pump procedures
  • redo procedures
  • Subjects with existing pacemakers, AICD
  • Vulnerable population
  • Emergent surgery
  • Currently participating in investigational drug or device study.
  • Subjects currently on antiarrhythmic drugs Class I and III including amiodarone.

Sites / Locations

  • Spectrum Health Hospitals

Arms of the Study

Arm 1

Arm 2

Arm Type

No Intervention

Experimental

Arm Label

Control group

Treatment group

Arm Description

Electric cardiac surgery only

Elective cardiac surgery plus prophylactic maze procedure

Outcomes

Primary Outcome Measures

Incidence or absence of documented post-operative atrial fibrillation
Per the STS registry definition of occurrence of postoperative atrial fibrillation that requires treatment.

Secondary Outcome Measures

number of participants requiring antiarrhythmic and anticoagulation medications in the treatment group versus control group
the utilization of antiarrhythmic medication and anticoagulation required to manage postoperative atrial fibrillation will be recorded
incidence of adverse events and outcomes related to use of the radiofrequency device or left atrial appendage amputation
record and describe any patient related morbidity or adverse outcome related to the radiofrequency pulmonary vein isolation or left atrial appendage removal

Full Information

First Posted
June 19, 2018
Last Updated
November 22, 2022
Sponsor
Spectrum Health Hospitals
search

1. Study Identification

Unique Protocol Identification Number
NCT03604432
Brief Title
Prophylactic Maze to Prevent Atrial Fibrillation in Adult Cardiac Surgery
Acronym
PREVENT-AF
Official Title
Prophylactic Limited Left Sided Maze Procedure to Prevent Post-operative Atrial Fibrillation in Adult Cardiac Surgery Patients
Study Type
Interventional

2. Study Status

Record Verification Date
November 2022
Overall Recruitment Status
Active, not recruiting
Study Start Date
February 1, 2020 (Actual)
Primary Completion Date
December 31, 2024 (Anticipated)
Study Completion Date
December 31, 2024 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Spectrum Health Hospitals

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
Yes
Device Product Not Approved or Cleared by U.S. FDA
Yes
Product Manufactured in and Exported from the U.S.
Yes
Data Monitoring Committee
Yes

5. Study Description

Brief Summary
This study will look at performing a prophylactic limited left sided maze procedure during concomitant adult cardiac surgery to prevent the common occurrence of postoperative atrial fibrillation.
Detailed Description
This is a prospective, single site, randomized, small feasibility study using a FDA approved device for a new indication. Subjects undergoing a CABG, AVR, or CABG/AVR will be randomized 1 to 1 to a control or treatment group. The control group will undergo their index cardiac surgery procedure only. The treatment group will undergo their index cardiac procedure along with a limited left sided maze procedure. The maze procedure will be done with the Atricure synergy ablation system. This is an FDA approved device that will be used for this new indication. The left sided limited maze procedure will consist of pulmonary vein isolation and removal of the left atrial appendage. A total of 60 subjects will be enrolled in this study at a single site.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Coronary Artery Disease

7. Study Design

Primary Purpose
Prevention
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
60 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Control group
Arm Type
No Intervention
Arm Description
Electric cardiac surgery only
Arm Title
Treatment group
Arm Type
Experimental
Arm Description
Elective cardiac surgery plus prophylactic maze procedure
Intervention Type
Device
Intervention Name(s)
propylactic maze
Other Intervention Name(s)
Atricure synergy ablation system
Intervention Description
Prophylactic limited left sided maze procedure for subjects in the treatment arm
Primary Outcome Measure Information:
Title
Incidence or absence of documented post-operative atrial fibrillation
Description
Per the STS registry definition of occurrence of postoperative atrial fibrillation that requires treatment.
Time Frame
On average outcome 1 occurs 1 week post-procedure. From date of index surgical procedure to date of discharge from the hospital measured in total days
Secondary Outcome Measure Information:
Title
number of participants requiring antiarrhythmic and anticoagulation medications in the treatment group versus control group
Description
the utilization of antiarrhythmic medication and anticoagulation required to manage postoperative atrial fibrillation will be recorded
Time Frame
immediately after procedure/surgery up to discharge from the hospital.
Title
incidence of adverse events and outcomes related to use of the radiofrequency device or left atrial appendage amputation
Description
record and describe any patient related morbidity or adverse outcome related to the radiofrequency pulmonary vein isolation or left atrial appendage removal
Time Frame
during the procedure/surgery.

10. Eligibility

Sex
All
Minimum Age & Unit of Time
70 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Elective cardiac surgery AVR CABG AVR/CABG Exclusion Criteria: History of AF/Aflutter Less common cardiac surgeries: aortic root replacement aortic dissections myxoma pericardectomies off-pump procedures redo procedures Subjects with existing pacemakers, AICD Vulnerable population Emergent surgery Currently participating in investigational drug or device study. Subjects currently on antiarrhythmic drugs Class I and III including amiodarone.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Charles L Willekes, MD
Organizational Affiliation
Spectrum Health Hospitals
Official's Role
Principal Investigator
Facility Information:
Facility Name
Spectrum Health Hospitals
City
Grand Rapids
State/Province
Michigan
ZIP/Postal Code
49503
Country
United States

12. IPD Sharing Statement

Learn more about this trial

Prophylactic Maze to Prevent Atrial Fibrillation in Adult Cardiac Surgery

We'll reach out to this number within 24 hrs